Phathom

Phathom Pharmaceuticals is focused on the commercialization and development of novel treatments for gastrointestinal diseases.

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2019
Stage of Initial Investment
Series A
Initial Investment Year
2019